Updated
BioventusBVS · Healthcare
$10.61-0.66%
Market cap$894M
IndustryMedical Devices

Bioventus (BVS) Superinvestor holders

14 of the superinvestors we track hold Bioventus (BVS) in their latest 13F filings, $105M in total.

Summary

The largest holder is Wilmot Harkey (Nantahala Capital Management), with $57M, 3.4% of the portfolio.

In their latest quarter: 4 opened a new position, 3 added, 6 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Wilmot Harkey
Nantahala Capital Management
Trimmed 6,000,279$57M 3.4%Q2 2026
Chuck Royce
Royce Investment Partners
Trimmed 1,609,160$22M 0.2%Q3 2026
Arnaud Ajdler
Engine Capital
Added 900,558$9M 0.8%Q2 2026
Jim Simons
Renaissance Technologies
Added 736,000$7M 0.0%Q2 2026
Cliff Asness
AQR Capital Management
Trimmed 326,124$3M 0.0%Q2 2026
Two Sigma
Two Sigma Investments
Trimmed 230,625$2M 0.0%Q2 2026
Steve Cohen
Point72 Asset Management
New position 169,713$2M 0.0%Q2 2026
Arrowstreet Capital New position 158,690$1M 0.0%Q2 2026
Man Group
Man Group plc
New position 64,589$609,720 0.0%Q2 2026
Paul Tudor Jones
Tudor Investment Corp
New position 61,117$576,944 0.0%Q2 2026
Josef Lakonishok
LSV Asset Management
Added 35,800$488,000 0.0%Q3 2026
David Shaw
D. E. Shaw & Co.
Trimmed 47,304$446,550 0.0%Q2 2026
Peter Muller
PDT Partners
Held 42,113$397,547 0.0%Q2 2026
Acadian
Acadian Asset Management
Trimmed 5,679$77,000 0.0%Q3 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202614
Q1 202612
Q4 202511
Q3 20258
Q2 202510
Q1 202512
Q4 202410
Q3 202410

Questions about Bioventus

Which superinvestors own Bioventus?

14 of the superinvestors we track hold Bioventus (BVS) in their latest 13F filings, $105M in total. Wilmot Harkey, Chuck Royce, Arnaud Ajdler, Jim Simons, Cliff Asness, Two Sigma.

Who is the largest superinvestor holder of BVS?

The largest holder is Wilmot Harkey (Nantahala Capital Management), with $57M, 3.4% of the portfolio.

From Bioventus's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Bioventus and thousands of other companies, in one place. Free to start.